Fundz
You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →

Nutriventia secures a strategic growth investment from NDude Labs to accelerate its global expansion. The funding will enhance clinical R&D and scale its portfolio of proprietary ingredients.

PRIVATESep 18, 2026•about 3 hours ago

Round Type

Venture - Series Unknown

MumbaiBiotechnologyPharmaceutical

Investors

N Dude Labs

Description

Nutriventia has announced the closing of a strategic growth investment from NDude Labs. The capital will support clinical R&D and expand Nutriventia's portfolio of branded ingredients. Additionally, the investment will help establish dedicated U.S. commercial operations

Company Information

Company

Nutriventia

Location

Mumbai, Maharashtra, India

About

Nutriventia is redefining what rigor looks like in nutraceutical ingredient science, building clinically substantiated actives held to the same standard as pharmaceutical development, not just industry claims. Backed by more than 40 years of pharmaceutical-grade expertise, the company has turned the supplement industry's hardest problems, bioavailability, efficacy, and dose delivery, into a defensible competitive edge. Their portfolio includes proprietary, clinically substantiated branded ingredients such as TurmXTRA, Ashwanova (Prolanza), Melotime, CaffXtend, C-Fence, and ALAXTRA.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nutriventia raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015
Predictive Intelligence
Strategic

ML-powered predictions for Nutriventia's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Nutriventia raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.